
CAS 1422435-39-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylicAcidEthylEsterHydrochloride
CAS :Formule :C19H22ClN5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :387.8633Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)
CAS :Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)Degré de pureté :98%Masse moléculaire :387.86g/molDabigatran Impurity 9 HCl
CAS :Formule :C19H21N5O2·HClCouleur et forme :White To Off-White SolidMasse moléculaire :351.41 36.46Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)
CAS :Degré de pureté :97%Masse moléculaire :387.87Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran ethyl ester hydrochloride
CAS :Produit contrôlé<p>Applications 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride is derived from Dabigatran (D100090), which is a non-peptide, direct thrombin inhibior and anti-thrombotic.<br>References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)<br></p>Formule :C19H21N5O2·(HCl)Couleur et forme :NeatMasse moléculaire :351.40 + (36.46)




